(lp0
S"Catalyst Pharma shares jump 22% premarket on news of positive trial results ... MarketWatch - Mar 15, 2017 Shares of Catalyst Pharmaceuticals Inc. CPRX, +1.99% jumped 22% in premarket trade Wednesday, after the biotech reported positive data from a trial of a treatment for a form of myasthenia gravis, a rare neuromuscular disease, for which there is ...Catalyst Pharmaceuticals Inc : Here's What's Next - Market ExclusiveCatalyst Pharma positive trial data of a treatment for a rare neuromuscular ... - Proactive Investors USA & Canada"
p1
aS"Catalyst Pharma Neuromuscular Drug Succeeds  Investopedia - Mar 15, 2017 surged more than 51% to hit a 52-week high of $1.77 per share on Wednesday morning after the company announced positive top-line results from a clinical trial of its neuromuscular drug Firdapse .Catalyst Pharmaceuticals' neuromuscular drug succeeds in seven-patient trial - Pharmaceutical Business Review"
p2
aS'Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2016 Financial ... GlobeNewswire  - Mar 15, 2017 CORAL GABLES, Fla., March 15, 2017  -- Catalyst Pharmaceuticals, Inc.  , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular&nbsp;...'
p3
aS'Analytical Guide for New York Community Bancorp, Inc. , Catalyst ... The USA Commerce - Mar 17, 2017 Shares of New York Community Bancorp, Inc.  surged 0.14% to $14.36. During the trading on 03/16/2017. The relative strength index or RSI highlights overbought  and oversold  areas.'
p4
aS"Roth Capital Weighs in on Catalyst Pharmaceuticals Inc  Following ... Smarter Analyst - Oct 13, 2016 Roth Capital analyst Scott Henry is out today with a research note on shares of Catalyst Pharmaceuticals Inc , following recent meeting with the company's senior management."
p5
aS'Broadfin Capital is Buying Catalyst Pharmaceuticals Inc.  Shares Small Cap Exclusive  - Feb 13, 2017 In a just published Form 13, filed with the US Securities and Exchange Commission , Catalyst Pharmaceuticals Inc.  reported that Broadfin Capital has picked up 8,200,000 of common stock as of 2017-02-13.'
p6
aS'Catalyst Pharmaceuticals Inc  to Release Earnings on Wednesday Chaffey Breeze - Mar 14, 2017 Catalyst Pharmaceuticals logo Catalyst Pharmaceuticals Inc  is scheduled to post its quarterly earnings results after the market closes on Wednesday, March 15th.'
p7
aS'Catalyst Pharmaceuticals: Why This $1 Biotech Stock Is A Strong Buy For 2017 Seeking Alpha - Jan 4, 2017 I have recently found a couple of very interesting investment opportunities that offer an excellent risk to reward ratio and one of the stocks I am bullish on now is Catalyst Pharmaceuticals, Inc. . As we can see from the chart below, 2016 ...'
p8
aS'Catalyst Pharma : What???s in Store in Q4 Earnings? Yahoo Finance - Mar 7, 2017 Catalyst Pharmaceuticals, Inc. CPRX is expected to report fourth-quarter 2016 results this month. Last quarter, the company recorded a positive earnings surprise of 16.67%.Catalyst Pharmaceutical Partners, Inc.  Broker Price Targets For The ... - Fiscal Standard'
p9
aS'BUZZ-US STOCKS ON THE MOVE-Catalyst Pharma, Magicjack, Rubicon Project Nasdaq - Mar 15, 2017 CATALYST PHARMACEUTICALS INC &lt;CPRX.O&gt;, $1.61, +37.29 pct The company said its experimental drug to treat patients with a severe form of myasthenia gravis, a rare neuromuscular disease, met the main goals of a study.US STOCKS ON THE MOVE-Catalyst Pharma, MSCI, Rubicon Project - Times of India'
p10
a.